Top Penny Stocks To Watch In October 2026

Over the last 7 days, the market has remained flat, but it is up 9.2% over the past year with earnings forecasted to grow by 17% annually. In this context, identifying stocks with strong financials and clear growth potential can be particularly rewarding for investors. Although "penny stocks" may sound like a term from the past, they still represent smaller or less-established companies that could offer significant value when built on solid fundamentals.

We'll examine a selection from our screener results.

Nautilus Biotechnology (NAUT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nautilus Biotechnology, Inc. is a development stage life sciences company focused on creating a platform technology to quantify and unlock the complexity of the proteome in the United States, with a market cap of $310.50 million.

Operations: Nautilus Biotechnology has not reported any revenue segments as it is still in the development stage.

Market Cap: $310.5M

Nautilus Biotechnology remains a pre-revenue company, with recent earnings indicating minimal revenue of US$0.424 million for the first nine months of 2026 and a net loss of US$44.8 million. Despite its unprofitability, Nautilus holds no debt and has sufficient cash runway for over a year based on current free cash flow trends. The company's innovative Iterative Mapping technology has shown promise in proteomics research, potentially paving the way for future growth in disease biomarkers and drug targets. However, its share price volatility and lack of profitability present significant risks to investors considering penny stocks like Nautilus.

• Jump into the full analysis health report here for a deeper understanding of Nautilus Biotechnology.
• Evaluate Nautilus Biotechnology's prospects by accessing our earnings growth report.

Aurora Innovation (AUR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Aurora Innovation, Inc. operates in the self-driving technology sector in the United States with a market cap of $9.76 billion.

Operations: The company generates its revenue from the Computer Services segment, amounting to $5 million.

Market Cap: $9.76B

Aurora Innovation, operating in the self-driving technology sector, is currently unprofitable with minimal revenue of US$5 million. Despite this, it has a strong financial position with US$1.3 billion in short-term assets exceeding its liabilities and no debt. The company recently announced a memorandum of understanding with Charger Logistics to potentially deliver 500 driverless trucks by 2028, highlighting demand for its autonomous solutions. Aurora's growth prospects are supported by its Driver as a Service model and plans to scale operations significantly by 2030, but profitability remains distant amid high volatility and ongoing losses.

• Get an in-depth perspective on Aurora Innovation's performance by reading our balance sheet health report here.
• Gain insights into Aurora Innovation's outlook and expected performance with our report on the company's earnings estimates.

Hyliion Holdings (HYLN)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Hyliion Holdings Corp. designs and develops power generators for stationary and mobile applications, with a market cap of $532.22 million.

Operations: Hyliion Holdings generates revenue primarily from its Auto Parts & Accessories segment, totaling $9.25 million.

Market Cap: $532.22M

Hyliion Holdings, with a market cap of US$532.22 million, is navigating challenges typical for penny stocks. Despite generating US$9.25 million in revenue primarily from its Auto Parts & Accessories segment, the company remains unprofitable and faces legal issues related to alleged misleading statements and insider trading. However, Hyliion's recent US$41.7 million military contract underscores potential growth in defense applications for its KARNO Power Modules. The firm has raised its 2026 revenue guidance to US$15 million following this contract win but continues to experience high share price volatility and negative return on equity at -30.78%.

• Navigate through the intricacies of Hyliion Holdings with our comprehensive balance sheet health report here.
• Review our growth performance report to gain insights into Hyliion Holdings' future.

Key Takeaways

• Jump into our full catalog of 333 US Penny Stocks here.
• Ready To Venture Into Other Investment Styles? The end of cancer? These 38 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com